INNOVADERM CRO IS NOW INDERO.

Eureka! Insights from EULAR 2026, Rheumatology’s Euro-Bonanza

PMR and PsA and SSc… Oh my! So much innovation discussed earlier this month at the mammoth rheumatology scientific congress of EULAR – the European Alliance of Associations for Rheumatology, in London, England. During days of wet and dark skies, EULAR 2026 was lit up with bright insights on rheumatology science and the business of conducting rheumatology clinical trials.  Indero’s rheumatology experts were among the almost 15,000 people at the congress. At an investigator advisory board the first day […]

Building Momentum in Clinical Trial Start‑Up

Delays in site start‑up remain one of the biggest obstacles to efficient clinical trial delivery, often caused by lengthy feasibility processes, protracted contract negotiations and poor communication between stakeholders. This International Clinical Trials article, written by Esther Sanchez, Associate Director, Start-Up at Indero, highlights practical insights on how to overcome these challenges through data‑driven site […]

Systemic Sclerosis Case Study

Click here for a PDF version of this case study Outcomes Effective study design and patient management leading to high patient retention (only 4% discontinuation). Patient recruitment was completed on time without any advertisement despite longer timelines associated with academic sites and the institutional burden.   Study Characteristics Disease Focus: Systemic Sclerosis (SSc), including subgroups Raynaud’s […]

Top Rheumatology Conferences to Attend

The rheumatology clinical research industry thrives on innovation, collaboration, and scientific advancements. Conferences are essential in nurturing these aspects, offering platforms for experts to exchange knowledge, discuss breakthroughs, and join forces to achieve the ultimate common goal: discovering new therapies and improving patients’ lives. Here, we highlight the top rheumatology conferences that make significant contributions […]

The Strategic Power of Public Relations in Scientific and Technical Industries

With 2 decades of experience in marketing across scientific, technical, and medical B2B sectors, Sarah Ballard, Agency Director at kdm communications, brings insight into the role of public relations (PR). Known for her strategic mindset and empathetic leadership, Sarah has helped numerous organizations navigate the complexities of integrated communications and build impactful PR campaigns. In […]

Rethinking CRA Oversight

With more than 25 years of experience in clinical research, Isabel Dorion, Senior Director of Clinical Operations at Indero, has played a pivotal role in advancing trials from phase I through IV. Her deep understanding of both site-level operations and the complexities of the CRO landscape positions her as a leader in driving operational excellence. […]

What Sites Look for in Sponsors: A Practical Checklist

The relationship between sponsors and investigative sites is more critical than ever. Sites are not just service providers, they are essential partners in delivering high-quality, efficient, and ethical clinical trials. Yet, many sponsors and CROs fall short in meeting site expectations, leading to operational inefficiencies, diminished motivation, and even site attrition.   Contributing their expert insights […]

A Site-Centric Approach to Protocol Usability

Protocol usability is a critical yet often overlooked factor in clinical trial efficiency. Errors and inconsistencies within protocols and supporting documents can lead to confusion, operational delays, and protocol deviations at research sites. This article explores how a site-centric approach emphasizing clarity, integration, and operational feasibility can significantly reduce these issues and enhance trial execution. […]

Enhancing Representation: Strategies for Patient Centricity in Inclusive Clinical Trials

Regulatory bodies are increasingly emphasizing patient centricity in clinical trials, reshaping their design to prioritize patient needs and experiences. John Clarke, Associate Director of Patient Recruitment at Indero, leverages his extensive experience in clinical research and patient recruitment to navigate this evolving landscape. This discussion explores how new guidelines are enhancing patient involvement, ensuring diverse […]

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.